Olema Pharmaceuticals Inc.
OLMA | NASDAQ
$9.64
-$0.18 (-1.83%)
At close: Sep 21, 2026, 4:00 PM ET
$9.81
+$0.17 (+1.76%)
Pre-market:
Sep 22, 2026, 5:49 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -63.2M | -53.09M | -46.06M | -42.22M | -43.78M | -30.39M | -33.57M | -34.56M | -30.38M | -30.97M | -26.77M | -21.5M | -20.1M | -28.29M | -26.18M | -22.72M | -32.86M | -23.03M | -21.64M | -17.71M | -16.41M | -15.34M |
Depreciation & Amortization | 102K | 119K | 187K | 43K | 132K | 128K | 116K | 95K | 94K | 88K | 88K | 90K | 425K | 427K | 97K | 418K | 410K | 407K | 73K | 50K | 31K | 9K |
Stock-Based Compensation | 12.9M | n/a | 4.27M | 4.25M | 4.69M | 4.38M | 6.32M | 5.63M | 5.72M | 4.91M | 4.35M | 4.11M | n/a | n/a | 4.86M | n/a | n/a | n/a | 4.63M | 4.16M | n/a | 3.21M |
Other Working Capital | 1.77M | 3.49M | -1.64M | 2.03M | 9.76M | -11.97M | -347K | 5.2M | 2.22M | -414K | 5.31M | -5.16M | -6.47M | 3.4M | 1.4M | 331K | 1.44M | -496K | -2.79M | 1.53M | 3.47M | 1.3M |
Other Non-Cash Items | 4.43M | 9.18M | -856K | -1.02M | -1.43M | -1.81M | -1.33M | -1.71M | -1.9M | -2.07M | -1.95M | 320K | 3.08M | 3.76M | -245K | 4.09M | 4.7M | 4.97M | 1.28M | 82K | 3.99M | 64K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -133K | -2.19M | 4.14M | 4.42M | 10.5M | -16.28M | 2.18M | 3.53M | -1.09M | 4.54M | 5.8M | -4.58M | -5.52M | 3.71M | 1.76M | 225K | 1.29M | -251K | -2.95M | 1.33M | 3.48M | 974K |
Operating Cash Flow | -45.9M | -45.99M | -38.33M | -34.53M | -29.88M | -43.98M | -26.28M | -27.02M | -27.56M | -23.5M | -18.48M | -22.74M | -22.12M | -20.39M | -19.71M | -17.99M | -26.46M | -17.9M | -18.6M | -12.1M | -8.91M | -11.08M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6K | -153K | n/a | n/a | n/a | n/a | -173K | -139K | -21K | -30K | -699K | -96K | -360K | -420K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 459K |
Purchase of Investments | -48.24M | -69.94M | -253.35M | -71.65M | -32.86M | -142.86M | -189.23M | -47.48M | -82.16M | -76.09M | -84.92M | -95.95M | -50.39M | -24.37M | -44.49M | -18.45M | -27.57M | -123.15M | -19.96M | -132.14M | -54.71M | -280.16M |
Sales Maturities Of Investments | 89.3M | 74.47M | 91.17M | 88.93M | 67.1M | 97.77M | 74.81M | 93.4M | 77.29M | 56.1M | 54M | 70.5M | 64.5M | 61.76M | 61M | 38.75M | 57M | 148.75M | 26.66M | 119.45M | 66M | 1M |
Other Investing Acitivies | -221K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -459K |
Investing Cash Flow | 40.84M | 4.53M | -162.18M | 17.27M | 34.23M | -45.08M | -114.42M | 45.92M | -4.88M | -20.14M | -30.92M | -25.44M | 14.11M | 37.39M | 16.34M | 20.16M | 29.41M | 25.57M | 6M | -12.78M | 10.93M | -279.58M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 4.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -4.41M | n/a | n/a | -3.5M | n/a | 799K | n/a | 719K | 920K | 547K | 869K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 1.11M | 45.7M | 213.55M | 41K | -2.52M | 222K | 244.3M | 92K | 15.61M | 8.82M | 523K | 130.63M | 2.04M | 220K | 273K | 106K | 64K | 33K | 818K | 57K | 516K | n/a |
Net Cash Flow | -3.95M | 4.25M | 13.04M | -17.21M | 1.83M | -88.84M | 103.59M | 19M | -16.83M | -34.82M | -48.87M | 82.45M | -5.96M | 17.22M | -3.1M | 2.28M | 3.02M | 7.7M | -11.79M | -24.83M | 2.54M | -290.67M |
Free Cash Flow | -45.9M | -45.99M | -38.33M | -34.53M | -29.88M | -43.98M | -26.28M | -27.02M | -27.56M | -23.65M | -18.48M | -22.74M | -22.12M | -20.39M | -19.88M | -18.13M | -26.48M | -17.93M | -19.3M | -12.19M | -9.27M | -11.5M |
Adj. Free Cash Flow | -58.8M | -45.99M | -42.59M | -38.78M | -34.58M | -48.36M | -32.61M | -32.64M | -33.29M | -28.56M | -22.83M | -26.85M | -22.12M | -20.39M | -24.75M | -18.13M | -26.48M | -17.93M | -23.93M | -16.35M | -9.27M | -14.71M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6K | -88K | n/a | n/a | n/a | n/a | -97K | -139K | -21K | -30K | -73K | -50K | -31K | -9K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -65K | n/a | n/a | n/a | n/a | -76K | n/a | n/a | n/a | -626K | -46K | -329K | -411K |
Owner Earnings | -45.9M | -45.99M | -38.33M | -34.53M | -29.88M | -43.98M | -26.28M | -27.02M | -27.56M | -23.58M | -18.48M | -22.74M | -22.12M | -20.39M | -19.81M | -18.13M | -26.48M | -17.93M | -18.68M | -12.15M | -8.94M | -11.09M |
Add to Watchlist
Select watchlists to add or remove OLMA